Pilot and Translational Study of Dasatinib (NSC#732517) Paclitaxel and Carboplatin in Women With Advanced Stage and Recurrent Endometrial Cancer
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 15 Dec 2017
At a glance
- Drugs Dasatinib (Primary) ; Carboplatin; Paclitaxel
- Indications Endometrial cancer
- Focus Pharmacogenomic; Therapeutic Use
- 10 Jul 2017 Planned End Date changed from 1 Jul 2015 to 1 Dec 2017.
- 22 Dec 2015 Planned End Date changed from 1 Jun 2014 to 1 Jul 2015, according to ClinicalTrials.gov record.
- 22 Dec 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Jul 2015, according to ClinicalTrials.gov record.